Screening for Psychosis in Adolescents: Consideration of the Knowns and Unknowns

The live presentation will take place on May 28, 2020, 10:00-11:00amPST/1:00-2:00pmEST

Register in advance for this webinar:

After registering, you will receive a confirmation email containing information about joining the webinar.



We know that the early signs of emerging psychotic disorders present prior to adulthood for a majority of affected individuals. We also know that intervening early in the course of psychotic illnesses can have meaningful implications for the clinical trajectories of young people. We know how to reliably identify adolescents and young adults at imminent risk for the onset of a psychotic disorder and reduce their short-term risk of transition. We have screening tools to identify psychotic and psychotic-like symptoms. So why not screen all adolescents for psychosis? This webinar will review the available data on psychotic-spectrum experiences in adolescents and the challenges to identifying candidates for specialized intervention. This will include a review of basic screening concepts, methods, and tools as well as a discussion of their limitations, particularly in adolescent samples. We will end with considerations for clinicians who want to screen adolescents for psychosis.



FREE - $0

Funding for this initiative was made possible (in part) by Grant No. 1H79SM080818-01 from SAMHSA. The views expressed in written conference materials or publications and by speakers and moderators do not necessarily reflect the official policies of the Department of Health and Human Services; nor does mention of trade names, commercial practices, or organizations imply endorsement by the U.S. Government.

Learning Objectives

1.     Explain the difference between the screening concepts of sensitivity and specificity and the relevance of sampling.

2.     Describe the basic frequency and specificity of psychotic-spectrum symptoms across adolescence.

3.     Identify three key considerations in screening adolescents for psychotic symptoms.

Target Audience

Counselor, Psychiatrist, Psychologist, Program Manager

Instructional Level

Introductory, Intermediate

Estimated Time to Complete

Estimated Duration: 1.0 hour
Program Start Date: April 30, 2020 
Program End Date: April 30, 2020

Attendees will have an opportunity to participate in Q&A.

How to Earn Credit

Participants who wish to earn AMA PRA Category 1 Credit™, CE credit for psychologists, or a certificate of participation may do so by attending the live presentation and completing the evaluation. Participants claiming CE credit for psychologists must attend the full presentation to claim credit. After evaluating the program, course participants will be provided with an opportunity to claim hours of participation and print an official CME certificate (physicians), CE certificate (psychologists), or certificate of participation (other professions) showing the event date and hours earned.

Continuing Education Credit


The American Psychiatric Association (APA) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. The APA designates this live event for a maximum of 1.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.


The American Psychiatric Association is approved by the American Psychological Association to sponsor continuing education for psychologists. American Psychiatric Association maintains responsibility for this program and its content.

Faculty and Planner Disclosures


Kristen Woodberry, MSW, PhD, is a clinical social worker, licensed clinical psychologist, and early psychosis researcher at the Maine Medical Center Research Institute and Beth Israel Deaconess Medical Center. A graduate of Bowdoin College, she obtained her MSW from Simmons College School of Social Work and her Ph.D. in Clinical Psychology from Harvard University. She is a Research Assistant Professor in the Psychiatry Department at the Tufts School of Medicine.


· Teri Brister, PhD, LPC, National Alliance on Mental Illness. Reports no financial relationships with commercial interests. 

·  Amy N. Cohen, PhD, American Psychiatric Association. Reports no financial relationships with commercial interests.

· Tristan Gorrindo, MD, American Psychiatric Association. Reports no financial relationships with commercial interests.

· Judith Dauberman, PhD, Stanford University. Reports no financial relationships with commercial interests.

Accessibility for Participants with Disabilities

PEPPNET is committed to ensuring accessibility of its website to people with disabilities.  Please contact PEPPNET at 650)723-2963, if you require assistance seven (7) days prior to the start of a live webinar.

For assistance: Contact for questions about this course and for technical assistance.

Hardware/Software Requirements

Supported operating systems

·         macOS X with macOS 10.7 or later

·         Windows 10

·         Windows 8 or 8.1

·         Windows 7

·         Windows Vista with SP1 or later

·         Windows XP with SP3 or later

·         Ubuntu 12.04 or higher

·         Mint 17.1 or higher

·         Red Hat Enterprise Linux 6.4 or higher

·         Oracle Linux 6.4 or higher

·         CentOS 6.4 or higher

·         Fedora 21 or higher

·         OpenSUSE 13.2 or higher

·         ArchLinux (64-bit only)

Supported tablet and mobile devices

·         Surface PRO 2 running Win 8.1

·         Surface PRO 3 running Win 10

·         iOS and Android devices

·         Blackberry devices

Supported browsers

·         Windows: IE 11+,  Edge 12+, Firefox 27+,  Chrome 30+

·         Mac: Safari 7+, Firefox 27+,  Chrome 30+

·         Linux: Firefox 27+,  Chrome 30+